Single Cell Multiomics Industry Growth Insights: Revenue Forecast to 2030

Uncover key drivers, emerging technologies, and competitive movements shaping the single cell multiomics market from 2026–2035 with trusted insights from The Business Research Company

What are the forecasted starting (2026) and ending (2030) market sizes for the Single Cell Multiomics Market?

The single cell multiomics market size has experienced substantial expansion in recent years. This market is projected to expand from $4.85 billion in 2025 to $5.92 billion in 2026, achieving a compound annual growth rate (CAGR) of 22.1%. The historic growth is linked to factors such as advancements in single-cell sequencing technologies, the expansion of cancer research initiatives, escalating investments in life sciences research, the increased availability of high-throughput analysis tools, and growing academic research funding.

The single cell multiomics market is projected to experience substantial expansion over the upcoming years, with its valuation anticipated to reach $13 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 21.7%. This projected increase can be ascribed to several factors, including a heightened need for precision medicine applications, greater integration into clinical research processes, the proliferation of multiomics data integration solutions, increased financial commitments to pharmaceutical research, and ongoing advancements in analytical sensitivity. Key developments expected during this period involve the wider implementation of integrated multiomics platforms, a growing requirement for high-resolution single-cell analysis, an expanding reliance on AI-powered data interpretation tools, the proliferation of multi-modal cellular profiling methods, and a sharpened emphasis on understanding cellular heterogeneity.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20630&type=smp

What Drivers Are Supporting Technological Adoption In The Single Cell Multiomics Market?

The single cell multiomics market is anticipated to grow in the future due to the increasing need for precision medicine. Precision medicine refers to a medical methodology that customizes treatment and healthcare strategies to suit the individual characteristics of each patient. The expansion of precision medicine is propelled by advancements in genomic research, enhanced capabilities for data analysis, and a clearer understanding of the advantages of personalized healthcare. Single-cell multiomics delivers comprehensive insights into cellular heterogeneity and molecular mechanisms, thereby enabling the creation of highly personalized treatments specifically adapted to individual patients’ distinct cellular profiles. For instance, in May 2025, as per the Personalized Medicine Coalition (PMC), a U.S.-based professional organization, the U.S. Food and Drug Administration (FDA) approved 18 new personalized medicines in 2023, which constituted about 38% of all newly approved therapeutic molecular entities. Thus, the growing demand for precision medicine is fueling the growth of the single cell multiomics market.

What Segment Types Are Examined In The Single Cell Multiomics Market?

The single cell multiomics market covered in this report is segmented –

1) By Type: Single Cell Genomics, Single Cell Proteomics, Single Cell Transcriptomics, Single Cell Metabolomics

2) By Technique: Single Cell Isolation And Dispensing, Single Cell Analysis

3) By Application: Oncology, Cell Biology, Neurology, Immunology, Stem Cell Research

4) By End User: Academic Institutes, Contract Research Organizations, Pharmaceutical And Biotech Companies

Subsegments:

1) By Single Cell Genomics: Whole Genome Sequencing (WGS), Targeted Sequencing, Single Cell DNA Amplification Techniques, Genomic Analysis Platforms

2) By Single Cell Proteomics: Mass Spectrometry-Based Techniques, Protein Microarrays, Enzyme-Linked Immunosorbent Assays (ELISA), Single Cell Protein Analysis Platforms

3) By Single Cell Transcriptomics: Single Cell RNA Sequencing (scRNA-seq), RNA Amplification Techniques, Microfluidics-Based Transcriptomics, Transcriptome Analysis Tools

4) By Single Cell Metabolomics: Mass Spectrometry For Metabolite Analysis, Nuclear Magnetic Resonance (NMR) Techniques, Liquid Chromatography For Metabolomics, Metabolite Profiling Tools

What Long-Term Trends Are Expected To Shape The Future Of The Single Cell Multiomics Market?

Leading companies operating in the single cell multiomics market are developing single-cell multiomics tests to enhance the precision and clarity of cellular analysis. These tests enable researchers to gain a deeper understanding of complex biological processes, identify infrequent cell populations, and tailor precision medicine approaches by integrating comprehensive molecular data from individual cells. For instance, in June 2024, Mission Bio, a US-based biotechnology company, launched its Tapestri Single-cell Multiple Myeloma Multiomics Solution, which facilitates extensive profiling of multiple myeloma at single-cell resolution. This solution empowers translational researchers and drug developers to thoroughly dissect the molecular and cellular landscape during myeloid progression, comprehend therapy resistance, and identify the driving factors of disease evolution from early stages such as monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM).

Who Are The Top-Performing Companies In The Single Cell Multiomics Market In Recent Years?

Major companies operating in the single cell multiomics market are Thermo Fisher Scientific Inc., Danaher Corporation, Becton Dickinson and Company, Illumina Inc., BioRad Laboratories Inc., QIAGEN N.V., BioTechne Corporation, Miltenyi Biotec BV & Co KG, BGI Genomics Co Ltd, 10x Genomics Inc., Molecular Devices LLC, NanoString Technologies Inc., Standard BioTools Inc., Akoya Biosciences Inc., Takara Bio Inc., Synthego Corporation, Mission Bio Inc., DeepCell Inc., RareCyte Inc., Parse Biosciences Inc., Dolomite Bio Ltd, Stilla Technologies SAS, NanoCellect Biomedical Inc., Epicypher Inc., Scipio Biosciences SAS

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/single-cell-multiomics-global-market-report

Which Region Currently Holds The Largest Share Of The Single Cell Multiomics Market?

North America was the largest region in the single cell multiomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single cell multiomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Single Cell Multiomics Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20630&type=smp

Browse Through More Reports Similar to the Global Single Cell Multiomics Market 2026, By The Business Research Company

Cellular Telephone Market Report 2026

https://www.thebusinessresearchcompany.com/report/cellular-telephone-global-market-report

Flow Cytometry In Oncology And Immunology Market Report 2026

https://www.thebusinessresearchcompany.com/report/flow-cytometry-in-oncology-and-immunology-global-market-report

Stem Cell Market Report 2026

https://www.thebusinessresearchcompany.com/report/stem-cell-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795